Immunic, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.17
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.66
|
-0.69
|
-0.03
|
-4.55%
|
|
2022-06-30
|
-0.72
|
-0.72
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.80
|
-0.74
|
0.06
|
7.50%
|
|
2021-12-31
|
-0.76
|
-0.72
|
0.04
|
5.26%
|
|
2021-09-30
|
-0.78
|
-0.76
|
0.02
|
2.56%
|
|
2021-06-30
|
-0.67
|
-0.82
|
-0.15
|
-22.39%
|
|
2021-03-31
|
-0.68
|
-1.63
|
-0.95
|
-139.71%
|
|
2020-12-31
|
-0.60
|
-0.46
|
0.14
|
23.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.15
|
|
2021-12-31
|
-3.93
|
|
2020-12-31
|
-2.85
|
|
2019-12-31
|
-3.81
|
|
2018-12-31
|
-39.20
|
|
2017-12-31
|
-53.20
|
|
2016-12-31
|
-1.30
|
|
2015-12-31
|
-2.10
|
|
2014-12-31
|
-1017.18
|